Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

uniQure N.V. - Ordinary Shares (NQ:QURE)

13.26 -0.23 (-1.70%)
Streaming Delayed Price Updated: 2:29 PM EDT, Aug 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 347,443
Open 13.50
Bid (Size) 13.24 (1)
Ask (Size) 13.27 (3)
Prev. Close 13.49
Today's Range 13.21 - 13.73
52wk Range 4.450 - 19.18
Shares Outstanding 54,865,673
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies. 
Via Benzinga
uniQure Narrows Loss in Fiscal Q2
Via The Motley Fool

Performance

YTD
-26.5%
-26.5%
1 Month
-7.3%
-7.3%
3 Month
+31.8%
+31.8%
6 Month
-17.8%
-17.8%
1 Year
+75.4%
+75.4%

More News

Read More
uniQure NV (NASDAQ:QURE) Posts Q2 2025 Earnings: EPS Beat Offsets Revenue Miss as Regulatory Progress Boosts Shares
Via Chartmill
uniQure Announces Second Quarter 2025 Financial Results and Highlights of Recent Company Progress
From uniQure Inc.
Via GlobeNewswire
Earnings Scheduled For July 29, 2025
Via Benzinga
uniQure Earnings Preview
Via Benzinga
Earnings Outlook For uniQure
Via Benzinga
uniQure to Announce Second Quarter 2025 Financial Results
From uniQure Inc.
Via GlobeNewswire
uniQure Announces Appointment of Kylie O’Keefe as Chief Customer and Strategy Officer
From uniQure Inc.
Via GlobeNewswire
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE)
From uniQure Inc.
Via GlobeNewswire
UniQure Narrows Q1 Loss But Revenue Plummets: Retail’s In Wait-And-Watch Mode
Via Stocktwits
uniQure Announces First Quarter 2025 Financial Results and Highlights of Recent Company Progress
From uniQure Inc.
Via GlobeNewswire
Earnings Scheduled For May 9, 2025
Via Benzinga
uniQure to Announce First Quarter 2025 Financial Results
From uniQure Inc.
Via GlobeNewswire
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
Via Investor's Business Daily
Topics Government
Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday
Via Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
Which stocks are moving on Thursday?
Via Chartmill
uniQure Stock Jumps On FDA’s Breakthrough Therapy Designation For Investigational Gene Therapy: Retail’s Optimistic
Via Stocktwits
Topics Bankruptcy
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
Why Is Gene Therapy Developer uniQure Stock Trading Higher On Thursday?
Via Benzinga
uniQure Announces FDA Breakthrough Therapy Designation Granted to AMT-130 for the Treatment of Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire

Frequently Asked Questions

Is uniQure N.V. - Ordinary Shares publicly traded?
Yes, uniQure N.V. - Ordinary Shares is publicly traded.
What exchange does uniQure N.V. - Ordinary Shares trade on?
uniQure N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for uniQure N.V. - Ordinary Shares?
The ticker symbol for uniQure N.V. - Ordinary Shares is QURE on the Nasdaq Stock Market
What is the current price of uniQure N.V. - Ordinary Shares?
The current price of uniQure N.V. - Ordinary Shares is 13.26
When was uniQure N.V. - Ordinary Shares last traded?
The last trade of uniQure N.V. - Ordinary Shares was at 08/07/25 02:29 PM ET
What is the market capitalization of uniQure N.V. - Ordinary Shares?
The market capitalization of uniQure N.V. - Ordinary Shares is 727.52M
How many shares of uniQure N.V. - Ordinary Shares are outstanding?
uniQure N.V. - Ordinary Shares has 728M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.